Advancing Immunotherapy: The Future of Tumour Necrosis Factor...

أضاف وظيفة جديدة Health

2025-10-13 08:11:42

Advancing Immunotherapy: The Future of Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitors

The therapeutic class of Tumour Necrosis Factor Ligand Superfamily Member 15 Inhibitor (TNFSF15 inhibitor) is emerging as a promising option for targeting TNFSF15, an immune-regulating protein involved in inflammatory, autoimmune, and oncological disorders. TNFSF15, also called TL1A, is central to T-cell activation, vascular inflammation, and cytokine signaling. Dysregulated TNFSF15 has been...

0 التعليقات 0 المشاركات 279 مشاهدة 0 معاينة